• Explore /
  • Poster
  • / The benefits of upfront primary tumor resection for metastatic small bowel neuroendocrine tumors: A population-based analysis.

The benefits of upfront primary tumor resection for metastatic small bowel neuroendocrine tumors: A population-based analysis.

Abstract Poster

Authors

null

Sean Bennett

University of Toronto, Toronto, ON, Canada

Sean Bennett , Natalie Coburn , Calvin Law , Victoria Zuk , Alyson Mahar , Simron Singh , Sten Myrehaug , Haoyu Zhao , Laura E Davis , Vaibhav Gupta , Julie Hallet

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Hepatobiliary Cancer, Neuroendocrine/Carcinoid, Pancreatic Cancer, and Small Bowel Cancer

Track

Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Pancreatic Cancer,Small Bowel Cancer,Other GI Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 620)

Abstract #

620

Poster Bd #

G1

Abstract Disclosures

Similar Posters

First Author: Emilio Bertani

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Timing of primary tumor resection after systemic chemotherapy initiation among patients with metastatic colon cancer.

Timing of primary tumor resection after systemic chemotherapy initiation among patients with metastatic colon cancer.

First Author: Munir Buhaya

First Author: Nuri Karadurmus

First Author: Benjamin Daniel Powers